Are you a researcher with compelling new data on the microbiome? Do you have exciting probiotic or prebiotic science to share? Would you like to present your findings at the leading microbiome-focused event? If so, its not too late to submit your abstract...
An antioxidant, astaxanthin has been linked to healthier skin, heart health, joint pain, and now, research suggests it may also reduce depression and stress in healthy subjects as well as improve memory in subjects with mild cognitive decline.
The shift in how nutritional studies are carried out are now adding additional insights into understanding biological mechanisms, disease biomarkers and identifying new intervention targets.
Adding probiotic bacteria to milk given to premature babies appears to decrease the risk of serious gut problems and infections with no safety issues reported, a UK study concludes.
Scientists from around the world are joining forces for the “Million Microbiome of Humans Project” (MMHP) in an aim to build the world’s largest database of the human microbiome.
A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.
Oral food challenges (OFCs) could help avoid mistreatment and can help avoid new allergies to arising, according to two medically challenging cases of two young boys presented at a scientific meeting last week.
Recurrent Clostridioides difficile infection (CDI) is better treated with faecal microbiota transplantation (FMT) than antibiotics, according to a new Italian study involving 290 patients.
Personalized nutrition is closing in on actionable endpoints that will help companies cost effectively help consumers take control of their personal health, an expert says.
New research funded by Pharmactive Biotech Products has shown that saffron taken in conjunction with pharmaceutical antidepressants may assist adults with depression.
French probiotic firm TargEDys is conducting an ongoing clinical trial to study the benefits of its probiotic strain on weight reduction in overweight subjects, as part of its ambition to help tackle the global obesity issue.
